Global Veterinary Vaccines Market Insights, Forecast to 2025

  • ID:PD007170
  • October 2019
  • QY Research
                          

Veterinary Vaccines Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Veterinary Vaccines Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Veterinary Vaccines market.
 
This research report categorizes the global Veterinary Vaccines market by top players/brands, region, type and end user. This report also studies the global Veterinary Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
 
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.
 
The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.
 
The global Veterinary Vaccines market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.
 
The objectives of this study are to define, segment, and project the size of the Veterinary Vaccines market based on company, product type, end user and key regions.
 
The following manufacturers are covered in this report, with sales, revenue, market share for each company:

  • Elanco
  • Merck
  • Merial
  • Zoetis
  • Advaxis
  • AmpliPhi Biosciences
  • Aratana Therapeutics
  • ARKO Labs
  • Bayer
  • CanFel Therapeutics
  • Ceva Animal Health
  • Colorado Serum
  • Epitopix
  • Genus
  • Hygieia Biological Laboratories
  • ImmuCell
  • Nexvet
  • Nuovo Biologics
  • UBI
  • Valneva
  • Vetoquinol
  • Virbac
Market size by Product
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Conjugate Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • DNA Vaccines
Market size by End User
  • Veterinary Clinic
  • Veterinary Hospital
  • Veterinary Research Institute
  • Retail Pharmacy
Market size by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa
The study objectives of this report are:
  • To study and analyze the global Veterinary Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
  • To understand the structure of Veterinary Vaccines market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Veterinary Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
  • To project the value and sales volume of Veterinary Vaccines submarkets, with respect to key regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Table of Contents - Guidelines
1 Study Coverage
1.1  Veterinary Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Veterinary Vaccines Market Size Growth Rate by Product
1.4.2 Inactivated Vaccines
1.4.3 Live Attenuated Vaccines
1.4.4 Conjugate Vaccines
1.4.5 Toxoid Vaccines
1.4.6 Recombinant Vaccines
1.4.7 DNA Vaccines
1.5 Market by End User
1.5.1 Global Veterinary Vaccines Market Size Growth Rate by End User
1.5.2 Veterinary Clinic
1.5.3 Veterinary Hospital
1.5.4 Veterinary Research Institute
1.5.5 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Veterinary Vaccines Market Size
2.1.1 Global Veterinary Vaccines Revenue 2013-2025
2.1.2 Global Veterinary Vaccines Sales 2013-2025
2.2 Veterinary Vaccines Growth Rate by Regions
2.2.1 Global Veterinary Vaccines Sales by Regions
2.2.2 Global Veterinary Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Veterinary Vaccines Sales by Manufacturers
3.1.1 Veterinary Vaccines Sales by Manufacturers
3.1.2 Veterinary Vaccines Sales Market Share by Manufacturers
3.1.3 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 Veterinary Vaccines Revenue by Manufacturers
3.2.1 Veterinary Vaccines Revenue by Manufacturers (2013-2018)
3.2.2 Veterinary Vaccines Revenue Share by Manufacturers (2013-2018)
3.3 Veterinary Vaccines Price by Manufacturers
3.4 Veterinary Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Veterinary Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Veterinary Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Veterinary Vaccines  Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Veterinary Vaccines Sales by Product
4.2 Global Veterinary Vaccines Revenue by Product
4.3 Veterinary Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Veterinary Vaccines Breakdown Data by End User
6 North America
6.1 North America Veterinary Vaccines by Countries
6.1.1 North America Veterinary Vaccines Sales by Countries
6.1.2 North America Veterinary Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Veterinary Vaccines by Product
6.3 North America Veterinary Vaccines by End User
7 Europe
7.1 Europe Veterinary Vaccines by Countries
7.1.1 Europe Veterinary Vaccines Sales by Countries
7.1.2 Europe Veterinary Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Veterinary Vaccines by Product
7.3 Europe Veterinary Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific Veterinary Vaccines by Countries
8.1.1 Asia Pacific Veterinary Vaccines Sales by Countries
8.1.2 Asia Pacific Veterinary Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Veterinary Vaccines by Product
8.3 Asia Pacific Veterinary Vaccines by End User
9 Central & South America
9.1 Central & South America Veterinary Vaccines by Countries
9.1.1 Central & South America Veterinary Vaccines Sales by Countries
9.1.2 Central & South America Veterinary Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Veterinary Vaccines by Product
9.3 Central & South America Veterinary Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa Veterinary Vaccines by Countries
10.1.1 Middle East and Africa Veterinary Vaccines Sales by Countries
10.1.2 Middle East and Africa Veterinary Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Veterinary Vaccines by Product
10.3 Middle East and Africa Veterinary Vaccines by End User
11 Company Profiles
11.1 Elanco
11.1.1 Elanco Company Details
11.1.2 Company Business Overview
11.1.3 Elanco Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Elanco Veterinary Vaccines Products Offered
11.1.5 Elanco Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Company Business Overview
11.2.3 Merck Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.2.4 Merck Veterinary Vaccines Products Offered
11.2.5 Merck Recent Development
11.3 Merial
11.3.1 Merial Company Details
11.3.2 Company Business Overview
11.3.Merial Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.3.4 Merial Veterinary Vaccines Products Offered
11.3.5 Merial Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Details
11.4.2 Company Business Overview
11.4.3 Zoetis Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Zoetis Veterinary Vaccines Products Offered
11.4.5 Zoetis Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Details
11.5.2 Company Business Overview
11.5.3 Advaxis Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Advaxis Veterinary Vaccines Products Offered
11.5.5 Advaxis Recent Development
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Details
11.6.2 Company Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.6.4 AmpliPhi Biosciences Veterinary Vaccines Products Offered
11.6.5 AmpliPhi Biosciences Recent Development
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Aratana Therapeutics Veterinary Vaccines Products Offered
11.7.5 Aratana Therapeutics Recent Development
11.8 ARKO Labs
11.8.1 ARKO Labs Company Details
11.8.2 Company Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.8.4 ARKO Labs Veterinary Vaccines Products Offered
11.8.5 ARKO Labs Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Business Overview
11.9.3 Bayer Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Bayer Veterinary Vaccines Products Offered
11.9.5 Bayer Recent Development
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Details
11.10.2 Company Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Sales, Revenue and Gross Margin (2013-2018)
11.10.4 CanFel Therapeutics Veterinary Vaccines Products Offered
11.10.5 CanFel Therapeutics Recent Development
11.11 Ceva Animal Health
11.12 Colorado Serum
11.13 Epitopix
11.14 Genus
11.15 Hygieia Biological Laboratories
11.16 ImmuCell
11.17 Nexvet
11.18 Nuovo Biologics
11.19 UBI
11.20 Valneva
11.21 Vetoquinol
11.22 Virbac
12 Future Forecast
12.1 Veterinary Vaccines Market Forecast by Regions
12.1.1 Global Veterinary Vaccines Sales Forecast by Regions 2018-2025
12.1.2 Global Veterinary Vaccines Revenue Forecast by Regions 2018-2025
12.2 Veterinary Vaccines Market Forecast by Product
12.2.1 Global Veterinary Vaccines Sales Forecast by Product 2018-2025
12.2.2 Global Veterinary Vaccines Revenue Forecast by Product 2018-2025
12.3 Veterinary Vaccines Market Forecast by End User
12.4 North America Veterinary Vaccines Forecast
12.5 Europe Veterinary Vaccines Forecast
12.6 Asia Pacific Veterinary Vaccines Forecast
12.7 Central & South America Veterinary Vaccines Forecast
12.8 Middle East and Africa Veterinary Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Veterinary Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..